R. W. Ross, The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic, The Journal of hygiene, vol.54, issue.2, pp.177-191, 1956.

J. H. Strauss and E. G. Strauss, The alphaviruses: gene expression, replication, and evolution, Microbiol Rev, vol.58, issue.3, pp.491-562, 1994.

R. S. Lanciotti, Chikungunya virus in US travelers returning from India, Emerg Infect Dis, vol.13, issue.5, pp.764-767, 2006.

R. Angelini, Chikungunya in north-eastern Italy: a summing up of the outbreak, Euro Surveill, vol.12, issue.11, 2007.

K. B. Chua, Epidemiology of chikungunya in Malaysia: 2006-2009, Med J Malaysia, vol.65, issue.4, pp.277-282, 2010.

V. Kumarasamy, Re-emergence of Chikungunya virus in Malaysia, Med J Malaysia, vol.61, issue.2, pp.221-225, 2006.

K. Laras, Tracking the re-emergence of epidemic chikungunya virus in Indonesia, Trans R Soc Trop Med Hyg, vol.99, issue.2, pp.128-141, 2005.

Y. S. Leo, Chikungunya outbreak, Emerg Infect Dis, vol.15, issue.5, pp.836-837, 2008.

L. Ng, Entomologic and virologic investigation of Chikungunya, Emerg Infect Dis, vol.15, issue.8, pp.1243-1249, 2009.

V. Ravi, Re-emergence of chikungunya virus in India, Indian J Med Microbiol, vol.24, issue.2, pp.83-84, 2006.

S. L. Seneviratne and J. Perera, Fever epidemic moves into Sri Lanka, Br Med J (Clin Res Ed), vol.333, issue.7580, pp.1220-1221, 2006.

V. Watanaveeradej, Transplacental Chikungunya virus antibody kinetics, Thailand. Emerg Infect Dis, vol.12, issue.11, pp.1770-1772, 2006.

A. Beltrame, Imported Chikungunya Infection, Italy. Emerg Infect Dis, vol.13, issue.8, pp.1264-1266, 2007.

G. Rezza, Infection with chikungunya virus in Italy: an outbreak in a temperate region, Lancet, vol.370, issue.9602, pp.1840-1846, 2007.

Z. Her, Chikungunya: a bending reality, Microbes Infect, vol.11, issue.14, pp.1165-1176, 2009.

P. Renault, A major epidemic of chikungunya virus infection on Reunion Island, Am J Trop Med Hyg, vol.77, issue.4, pp.727-731, 2005.

M. Enserink, Crippling Virus Set to Conquer Western Hemisphere, Science, vol.344, issue.6185, pp.678-679, 2014.

I. Leparc-goffart, Chikungunya in the Americas, Lancet, vol.383, issue.9916, p.514, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01213833

S. C. Weaver and N. L. Forrester, Chikungunya: Evolutionary history and recent epidemic spread, Antiviral Res, vol.120, pp.32-39, 2015.

R. A. Hawkes, Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls, Aust J Exp Biol Med Sci, vol.42, pp.465-482, 1964.

T. C. Pierson, Modeling antibody-enhanced dengue virus infection and disease in mice: protection or pathogenesis?, Cell Host Microbe, vol.7, issue.2, pp.85-86, 2010.

A. Takada and Y. Kawaoka, Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications, Rev Med Virol, vol.13, issue.6, pp.387-398, 2003.

, Antibody-mediated enhancement of rabies virus, SCIENTIfIC RePORts |, vol.8, issue.5807, p.542, 1981.

H. Ochiai, Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody, J Med Virol, vol.36, issue.3, pp.217-221, 1992.

D. M. Morens and S. B. Halstead, Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies, J Gen Virol, vol.71, issue.12, pp.2909-2914, 1990.

S. B. Halstead and E. J. O'rourke, Antibody-enhanced dengue virus infection in primate leukocytes, Nature, vol.265, issue.5596, pp.739-741, 1977.

M. L. Linn, Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis, J Gen Virol, vol.77, issue.3, pp.407-411, 1996.

W. E. Robinson, Antibody-dependent enhancement of human immunodeficiency virus type 1 infection, Lancet, vol.331, issue.8589, pp.790-794, 1988.

E. Nakayama, Antibody-dependent enhancement of Marburg virus infection, J Infect Dis, vol.204, issue.3, pp.978-985, 2011.

S. B. Halstead, Dengue Antibody-Dependent Enhancement: Knowns and Unknowns, Microbiol Spec, vol.2, issue.6, 2014.

B. A. Lidbury and S. Mahalingam, Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection, J Virol, vol.74, issue.18, pp.8376-8381, 2000.

S. Mahalingam and B. A. Lidbury, Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus, Proc Natl Acad Sci, vol.99, issue.21, pp.13819-13824, 2002.

W. Dejnirattisai, Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus, Nature immunology, vol.17, issue.9, pp.1102-1108, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-02003950

K. W. Ng, Clinical features and epidemiology of chikungunya infection in Singapore, Singapore Med J, vol.50, issue.8, pp.785-790, 2009.

M. K. Win, Chikungunya fever in Singapore: acute clinical and laboratory features, and factors associated with persistent arthralgia, J Clin Virol, vol.49, issue.2, pp.111-114, 2010.

M. Jaume, Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH-and cysteine protease-independent Fc?R pathway, J Virol, vol.85, issue.20, pp.10582-10597, 2011.

Z. Her, Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response, J Immunol, vol.184, issue.10, pp.5903-5913, 2010.

J. Hoarau, Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response, J Immunol, vol.184, issue.10, pp.5914-5927, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01285461

K. Labadie, Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages, J Clin Invest, vol.120, issue.3, pp.894-906, 2010.

T. Couderc, A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease, PLoS Pathog, vol.4, issue.2, p.29, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-01402310

J. Gardner, Chikungunya virus arthritis in adult wild-type mice, J Virol, vol.84, issue.16, pp.8021-8032, 2010.

T. Teo, A Pathogenic Role for CD4+T Cells during Chikungunya Virus Infection in Mice, J Immunol, vol.190, issue.1, pp.259-269, 2013.

Z. Her, Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response, EMBO Mol Med, vol.7, issue.1, pp.24-41, 2015.

Y. Kam, Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein, EMBO Mol Med, vol.4, issue.4, pp.330-343, 2012.

W. W. Lee, Expanding regulatory T cells alleviates chikungunya virus-induced pathology in mice, J Virol, 2015.

F. Lum, An essential role of antibodies in the control of chikungunya virus infection, J Immunol, vol.190, issue.12, pp.6295-6302, 2013.

T. Teng, Viperin restricts chikungunya virus replication and pathology, J Clin Invest, vol.122, issue.12, pp.4447-4460, 2012.

T. Teo, Caribbean and La Réunion Chikungunya virus isolates differ in their capacity to induce pro-inflammatory Th1 and NK cell responses and acute joint pathology, J Virol, 2015.

T. Couderc, Prophylaxis and Therapy for Chikungunya Virus Infection, J Infect Dis, vol.200, issue.4, pp.516-523, 2009.

S. B. Halstead, Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes, The Lancet Infectious diseases, vol.10, issue.10, pp.712-722, 2010.

K. Tsetsarkin, Infectious clones of Chikungunya virus (La Reunion isolate) for vector competence studies. Vector borne and zoonotic diseases, vol.6, pp.325-337, 2006.

R. Sallie, Replicative homeostasis: a mechanism of viral persistence, Med Hypotheses, vol.63, issue.3, pp.515-523, 2004.

T. Chareonsirisuthigul, Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells, J Gen Virol, vol.88, issue.2, pp.365-375, 2007.

M. S. Rolph, Downregulation of interferon-? in antibody-dependent enhancement of dengue viral infections of human macrophages is dependent on interleukin-6, J Infect Dis, vol.204, issue.3, pp.489-491, 2011.

A. Suhrbier and M. La-linn, Suppression of antiviral responses by antibody-dependent enhancement of macrophage infection, Trends Immunol, vol.24, issue.4, pp.165-168, 2003.

S. Ubol, Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies, J Infect Dis, vol.201, issue.6, pp.923-935, 2010.

E. I. Zuniga, Innate and Adaptive Immune Regulation During Chronic Viral Infections, Annu Rev Virol, vol.2, issue.1, pp.573-597, 2015.

K. Boonnak, Role of dendritic cells in antibody-dependent enhancement of dengue virus infection, J Virol, vol.82, issue.8, pp.3939-3951, 2008.

T. Hohdatsu, The role of IgG subclass of mouse monoclonal antibodies in antibody-dependent enhancement of feline infectious peritonitis virus infection of feline macrophages, Arch Virol, vol.139, issue.3-4, pp.273-285, 1994.

C. M. Midgley, Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity, J Immunol, vol.188, issue.10, pp.4971-4979, 2012.

Y. Kam, Longitudinal analysis of the human antibody response to chikungunya virus infection: implications for serodiagnosis assays and vaccine development, J Virol, vol.86, issue.23, pp.13005-13015, 2012.

Y. Kam, Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection, J Infect Dis, vol.205, issue.7, pp.1147-1154, 2012.

P. Palmeira, IgG placental transfer in healthy and pathological pregnancies, Clin Dev Immuno, vol.2012, p.985646, 2012.

J. K. Ng, First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies, PLoS Pathog, vol.10, issue.4, p.1004031, 2014.

D. Hallengärd, Prime-boost immunization strategies against Chikungunya virus, J Virol, vol.88, issue.22, pp.13333-13343, 2014.

Y. W. Kam, Sero-prevalence and cross-reactivity of chikungunya virus specific anti-E2EP3 antibodies in arbovirus-infected patients, PLoS Negl Trop Dis, vol.9, issue.1, p.3445, 2015.

H. Liu, Transcriptional diversity during monocyte to macrophage differentiation, Immunol Lett, vol.117, issue.1, pp.70-80, 2008.

M. Triggiani, Differentiation of monocytes into macrophages induces the upregulation of histamine H1 receptor, J Allergy Clin Immunol, vol.119, issue.2, pp.472-481, 2007.

, SCIENTIfIC RePORts |, vol.8, 2018.

L. Pohjala, Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays, PLoS One, vol.6, issue.12, p.28923, 2011.

B. Pastorino, Development of a TaqMan RT-PCR assay without RNA extraction step for the detection and quantification of African Chikungunya viruses, J Virol Methods, vol.124, issue.1-2, pp.65-71, 2005.

N. E. Plaskon, Accurate strand-specific quantification of viral RNA, PLoS One, vol.4, issue.10, p.7468, 2009.

A. I. Saeed, TM4: a free, open-source system for microarray data management and analysis, Biotechniques, vol.34, issue.2, pp.374-378, 2003.